Imagine a quick finger-prick blood test, similar to how people check glucose, but for strokes. It uses a smart app to analyze specific proteins in the blood to see if a major brain artery is blocked. This lets paramedics decide immediately if a patient needs a specialized surgery center instead of wasting time at a general hospital.
Current stroke triage relies on clinical scales that lack accuracy, leading to wrong hospital transfers and treatment delays. This results in irreversible brain damage and high long-term disability costs.
A point-of-care lateral flow assay for three blood biomarkers and an AI-based clinical decision support mobile app.
If you are an ambulance operator dealing with inefficient patient routing and triage delays — this project developed a portable diagnostic tool that identifies severe strokes in under 15 minutes. This allows direct transport to thrombectomy centers, saving an average of 2 hours from symptom onset to treatment.
If you are a diagnostics company dealing with the high cost and low mobility of Mobile Stroke Units — this project developed a lateral flow assay and AI app. It achieves 93% specificity, providing a scalable, low-cost alternative to heavy imaging equipment in the field.
If you are a health authority dealing with the high social and economic burden of long-term stroke disability — this project developed a triage system that increases the number of patients becoming asymptomatic or independent by 15-20%. This reduces long-term care costs by streamlining the care pathway.
Based on available project data, specific pricing is not listed, but the solution is described as a cost-effective alternative to expensive Mobile Stroke Units.
Yes, the project implemented a Quality Management System compliant with ISO 13485:2016 to support regulatory scalability.
Based on available project data, the company is pursuing FDA Breakthrough Device Designation and CE marking under EU IVDR, indicating a path toward commercial intellectual property protection.
The system is designed to fit seamlessly into existing emergency workflows via a mobile app and a simple finger-prick blood test in the ambulance.
The project has already initiated the FDA Breakthrough Device Designation submission and is preparing for CE marking under EU IVDR.
The project is led by a single Spanish SME, Advanced Brain Companion Diagnostics Spain SL. This 100% industry-led structure suggests a strong focus on commercialization and rapid market entry rather than academic research, supported by a significant EU contribution of EUR 2,772,276.
Contact Advanced Brain Companion Diagnostics Spain SL regarding the LVOCheck AI-supported diagnostic tool.
Contact us to explore licensing or partnership opportunities for this stroke triage technology.
